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Abstract: As more countries engage in water reuse, either intended or de facto, there is an urgent
need to more comprehensively evaluate resulting environmental and public health concerns. While
antibiotic-resistant bacteria (ARB) and antibiotic resistance genes (ARGs) are increasingly coming
under the spotlight, as emerging contaminants, existing water reuse regulations and guidelines do not
adequately address these concerns. This perspectives paper seeks to frame the various challenges that
need to be resolved to identify meaningful and realistic target types and levels of antibiotic resistance
benchmarks for water reuse. First, there is the need for standardized and agreed-upon methodologies
to identify and quantify ARB and ARGs. Second, even if methodologies are available, identifying
which ARB and ARGs to monitor that would best relate to the occurrence of disease burden remains
unknown. Third, a framework tailored to assessing the risks associated with ARB and ARGs during
reuse is urgently needed. Fourth, similar to protecting drinking water sources, strategies to prevent
dissemination of ARB and ARGs via wastewater treatment and reuse are required to ensure that
appropriate barriers are emplaced. Finally, current wastewater treatment technologies could benefit
from modification or retrofit to more effectively remove ARB and ARGs while also producing a
high quality product for water and resource recovery. This perspectives paper highlights the need
to consider ARB and ARGs when evaluating the overall safety aspects of water reuse and ways by
which this may be accomplished.
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1. Introduction: Benefits of Water Reuse
At least 45 countries worldwide face moderate to severe water scarcity issues [1]. Water stresses
are further compounded by the need to utilize freshwater for food production. Currently, about 70%
of the global freshwater supplies are withdrawn for agricultural irrigation [2]. Food production is
water-thirsty and with the projected increase in global human population from the current 7 billion
to 9.7 billion in 2050, the amount of water that is to be channeled into food production is expected to
increase. Intensive mining of groundwater supplies is unsustainable and alternative water resources
must be considered.
Worldwide, ~60% of all irrigated croplands fall within 20 km of an urban area, making irrigation
with municipal wastewater a potential option [3]. Municipal wastewater provides several advantages
over other alternative sources of irrigation water—It is a reliable water source for farmers, hence
expanding the growing season and the variety of crops that can be grown [4]. Furthermore, depending
on the degree of treatment, wastewater generally contains higher nutrient content as compared to
groundwater. Such nutrients can be assimilated by crops, which can increase crop yields and the
decrease reliance on chemical fertilizers. The intentional reuse of treated wastewater for agricultural
irrigation is already practiced throughout the world—about 5000 km2 are irrigated with treated
wastewater worldwide [1]. On the other hand, the majority of the world’s wastewater is not treated
and is discharged directly into the environment, contaminating surface waters. An estimated 2.9× 107 km2
of croplands (14% of all irrigated croplands) are dependent on surface waters that are likely to contain
a moderate to high fraction of inadequately treated wastewater [5].
The intentional reuse of treated wastewater for other non-potable purposes (e.g., landscape
irrigation, cooling towers, toilet flushing) also occurs throughout the world; in some cases, wastewater
is even being treated to permit potable reuse [6]. The majority of the wastewater treatment plants
(WWTP) worldwide utilize some form of settling and biological treatment, often with disinfection as
the final step. Activated sludge is one common type of biological treatment, and was first developed
more than one hundred years ago by Ardern and Lockett [7], with the main intention of reducing
organics through biodegradation and metabolic processes carried out by dense and highly active
microbial populations. Public health has improved drastically over the last century, with a marked
decrease in waterborne disease outbreak, as WWTPs became a widely implemented foundation of
urban infrastructure. Various benchmarks for assessing WWTP performance and resulting water
quality have evolved over the years, with most existing regulations requiring utilities to assess basic
parameters, such as total suspended solids, chemical oxygen demand, biochemical oxygen demand,
ammonia, nitrate, total phosphorus, and fecal coliforms or Escherichia coli.
In recent decades, “emerging” contaminants have been identified that may present “new”
environmental and public health concerns (designated as contaminants of emerging concern, CECs)
that are not necessarily represented by traditional means of assessing water quality. Substantial effort
has been placed on improving the activated sludge process and developing new and advanced
treatment technologies for removing pharmaceuticals and personal care products (PCPPs) [8,9].
However, most recent concerns regarding the need for water reuse to provide a safeguard against the
spread of antibiotic resistance remain to be addressed by the available treatment technologies and
existing regulations.
Given that the threat from antimicrobial resistance “has reached alarming levels in many parts
of the world and that in some settings, few, if any, of the available treatments options remain
effective for common infections” [10], urgent action is needed in all sectors, including water reuse.
Successive warnings that antibiotic resistance is one of the most serious human health threats have
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arisen in parallel with the growing evidence of rising levels of antibiotic-resistant bacteria (ARB) and
the antibiotic resistance genes (ARGs) that they carry in the aquatic environment associated with
anthropogenic inputs [10–12]. ARGs enable bacteria to survive in the presence of antibiotics and
belong to various classes corresponding to their mechanism of action and the class of antibiotic to
which they encode resistance. A general pattern has been observed, in which ARB and ARGs emerge
not long after new antibiotics are introduced to the market [13]. Correspondingly, ARGs associated
with particularly life-threatening infections, encoding resistance to a wide range of antibiotics, have
been detected in WWTPs or in the environment soon after the first reports of clinical cases [14,15].
Phenomena of proliferation, bioaccumulation, and transport have been observed for ARB and ARGs in
human-impacted environments, bringing to light the potential for exposure to humans and the need
to delineate possible health risks [11,16,17].
The fact that WWTPs receive wastewater that is laden with ARB and ARGs; along with residual
antibiotics, metals, and other potential selective agents, cannot be ignored, and it is thus critical to
establish fundamental understanding of the factors that contribute to their proliferation and dissipation
in the treatment process and to identify effective barriers to their dissemination during subsequent
reuse. Notably, the highly dense and active microbial populations within a WWTP are potentially an
ideal setting for selection of ARB and ARGs in treated effluents as well as a site for horizontal gene
transfer (HGT), or sharing, of ARGs among the bacterial populations. For example, bacteriophages
are found at extremely high concentrations in secondary sewage effluent, in the range of 107 to
108 virus-like particles (VLP) per milliliter [18], where HGT is possible as they mix with and infect the
dense bacterial populations at a high infection rate [19,20]. The active growing bacteria encourage
rapid lytic viral replication and large viral burst size [21], conditions that are well-suited for generalized
gene transfer by transduction, in which bacteriophages mistakenly pick up and transfer bacterial
DNA fragments, including ARGs [22]. Such concerns arising from ARB and ARGs may thus impede
subsequent efforts to reuse the treated wastewaters.
With this context in mind, there is a need to include a more comprehensive assessment of the
role of wastewater treatment and reuse in the propagation and dissemination of antibiotic resistance.
This will build up the needed scientific knowledge that is required to inform effective mitigation
strategies for ARB and ARGs and minimize the potential risks that are associated with water reuse.
Through this perspectives paper, the aim is to highlight the need to consider ARB and ARGs as
emerging contaminants in wastewater, to understand the risks that are incurred from ARB and ARGs
in water reuse contexts, and to lay out various intervention strategies that can be utilized to mitigate
the risks that are associated with these emerging contaminants. To achieve this aim, the following
outline topics are discussed in the context of antibiotic resistance and water reuse:
(i) Current regulations pertaining to microbiological water quality
(ii) Monitoring and surveillance associated with water reuse
(iii) Risk assessment of ARB and ARGs
(iv) Mitigation approaches to safeguard water quality for reuse
2. Current Regulations Pertaining to Microbiological Water Quality
Using the European Union (EU) as an example, in spite of the abundance of freshwater in most
European regions, the Wastewater Directive recommends that treated wastewater should be reused
whenever appropriate [23]. Although this recommendation was made as early as 1991, a common
European legislation on water reuse is still lacking to this date. Instead, some countries have developed
their own recommendations regarding the reuse of treated wastewater. Recommended parameters for
monitoring the quality of recycled water include microbiological parameters, in particular bacteria of
enteric origin and indicators of possible fecal contamination (see Table 1 and those that are listed by
Becerra-Castro et al. [24]).
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Table 1. Type of parameters and treatment objectives in different sectors of the urban water cycle
according to European legislation.
Type of Water Type of Parameters References
Wastewater
Chemical oxygen demand, COD
[23,25]
Biochemical oxygen demand, BOD—(can be replaced by total organic carbon,
TOC, or total oxygen demand, TOD)
(BOD5 at 20 ◦C)
Total suspended solids
Total phosphorus
Total nitrogen
Water for reuse
pH
See [24] for examples of
guidelines for Italy, Spain,
Portugal, France.
Electrical conductivity, EC
Sodium absorption rate, SAR
Total suspended solids, TSS
Biological oxygen demand, BOD
Chemical oxygen demand, COD
Total nitrogen, TN or Nitrate nitrogen, or N–NO3
Phosphate
Sulphate
Faecal coliforms or Escherichia coli
Nematode eggs
Surface water
45 priority substances or groups of substances, 21 of which classified as
priority hazardous substance. [26,27]
Includes plant protection products, biocides, metals and other groups like
Polyaromatic Hydrocarbons (PAH) that are mainly incineration by-products
and Polybrominated Biphenylethers (PBDE) that are used as flame retardants
Drinking water
A total of 48 microbiological, chemical and indicator parameters must be
monitored and tested regularly
[28]
Microbiological:
Escherichia coli
Enterococci
Pseudomonas aeruginosa
Clostridium perfringens including spores
Other heterotrophic bacteria
Note: Microbial contaminants are in bold.
Rationale for the assessment of water quality for reuse purposes is largely derived from minimum
quality requirements established for drinking water, in which the presence of bacteria of enteric
origin above a certain threshold is considered a criterion of non-compliance (Table 1). In the Drinking
Water Directive, target thresholds for various water quality parameters have been selected based on a
combination of scientific information and the precautionary principle. Generally, quality requirements
are established, assuming that water intended for human consumption must protect consumer
health on a life-long basis. For example, the World Health Organization (WHO) recommends
establishing water quality guidelines for different practices using a uniform risk-based approach
based on Disability-Adjusted Life Years (DALYs). This approach allows for risk to be quantified and
compared for all types of disease, including acute and chronic, infectious and non-infectious; where the
conversion from illness to DALYs is based on the severity of the disease [29]. A commonly used
acceptable burden of disease is 10−6 DALYs per person per year (pppy). This risk level corresponds to
maintaining genotoxins to levels that limit lifetime cancer risk to less than 1 in 100,000 per person [30].
This risk threshold is also recommended for establishing water quality targets for reuse in agriculture.
The corresponding tolerable risk for diarrheal pathogens is approximately 1 in 1000 annual risk per
person [31]. While this is a useful framework that could also be applied to assessing risk from ARB,
it is not straightforward, based on current data, to define equivalent risk endpoints.
Although fecal coliforms are commonly considered in guidelines of reclaimed water intended
for crop irrigation as indicators of fecal pathogens that cause diarrheal illness, ARB and ARGs are not
currently considered. There are various barriers to more meaningful and intentional guidelines to
protect against the spread of antibiotic resistance via water reuse. In particular, (i) the recognition of
the importance of ARB and ARGs as contaminants is relatively new; (ii) threshold values have not
been established and it will be difficult to do so; (iii) mechanisms that influence their selection and
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fate in water and wastewater treatment systems are still poorly understood; (iv) there are logistical
and economical challenges to putting in place cost-effective and sensitive monitoring and surveillance
methodologies; and (v) no consensus among the relevant stakeholders on the relative risk posed by
water reuse compared to other pathways that may contribute to the spread of antibiotic resistance.
Such challenges have motivated discussion centered on defining maximum admissible values
of ARB and ARGs in treated wastewater [11,32]. Ideally, the maximum admissible value should
correspond to the minimal risk of transmission and infection to humans. Such a value is still very
difficult to estimate in the face of limited knowledge about the most prominent sources, paths of
dissemination, and modes of transmission/colonization/infection in humans [17]. However, as for
other environmental contaminants, the application of the precautionary principle to the dissemination
of ARB and ARGs is logical.
Several questions arise in moving towards proposing maximum admissible values for ARB
and ARGs. First, even if a given threshold value is proposed and is possible to achieve through
wastewater treatment, it is not possible to guarantee that ARB and ARGs will not recover and proliferate
subsequently when the effluent is released to the environment. This is not unlikely, given the complex
microbial ecology and interplay among bacteria inhabiting sewer lines, water distribution system
biofilms, river sediments, groundwater, and other receiving environments. Thus, monitoring efforts
should ideally encompass such receiving environments, with selection of threshold targets and values
taking into consideration potential for survival, regrowth, and HGT between ARB and ARGs with
native bacteria residing in such environments. These phenomena are still not fully understood and are
difficult to predict.
To resolve this uncertainty, one can propose that a threshold of maximum admissible ARB or
ARGs in treated wastewater should be “low enough” to reduce the risk of subsequent proliferation
to very low levels (acceptable risk threshold). However, again there are some obstacles. One is
that it is difficult to define the “low enough” value; the other is that to propose such a threshold,
it would be necessary to guarantee that wastewater treatment and disinfection strategies could reach
such a low value in an affordable manner [33,34]. This may not be realistic, especially for smaller
wastewater treatment facilities and for low and middle-income regions. A second obstacle is that
routine monitoring methods to measure ARB and ARGs would need to be able to target such “low
levels”, meaning that very low quantification limits are required from these methods while maintaining
the important characteristics of low cost, ease of use, and rapid turnaround time for analysis.
3. Monitoring and Surveillance of Antibiotic Resistance
In clinical settings, the current procedure that is established to determine if bacteria isolated from
an infected host are resistant to antibiotics include cultivation, determination of phenotypic traits,
serotyping, and antimicrobial susceptibility tests [35]. However, such procedures are often not suitable
for use in environmental monitoring and surveillance programs given the cost and time requirements,
nor do they always provide quantitative information. Also, culture-based methods do not provide a
comprehensive picture of the broader ARG presence in the microbial community beyond the cultured
target and the potential for HGT unless deeper reconnaissance and sequencing of isolates is performed,
which is often impractical. However, knowing the abundance of a range of ARB along with ARGs they
carry in wastewater provides valuable information for assessing the potential risks to human health
through incorporation of wastewater unit process treatment efficiencies with risk models. Similarly,
knowing the abundance of ARB and ARGs in the final effluent of WWTP allows for one to refine the
assessment of treatment effectiveness and to determine the associated contaminant load discharged
into the environment.
To address the needs for quantitative measurements, one can utilize various approaches, such as
(i) enumeration of bacteria on antibiotic-supplemented culture media, (ii) quantitative polymerase chain
reaction (qPCR) targeting specific ARB or ARG per volume or mass of sample, and (iii) high-throughput
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DNA sequencing combined with measurement of total cell counts or total DNA, to allow determination
of the absolute abundance of cells or genes.
The recent advancement of metagenomics-based approaches have provided a powerful means
to give a snapshot of the diversity of ARGs and mobile genetic elements (MGEs) that facilitate
HGT (e.g., plasmids, integron gene cassettes) in wastewater and environmental samples [36,37].
Metagenomics also makes it possible to assess the roles of other microbes besides bacteria, such as
phages, in propagating resistance in WWTPs, as elucidated in a recent review paper [38].
To its credit, qPCR allows for the quantitation of gene targets with higher precision and lower
detection limits when compared with conventional endpoint PCR. For example, up to 104 gene copies
(GC) of beta-lactamase blaTEM gene, 102 GC of beta-lactamase blaCTX-M gene, and 102 GC of mecA
gene were found to be present in phages isolated from sewage [39]. Recent review papers have
collated abundance of ARGs determined by qPCR in various wastewater effluent streams [40,41],
while others discussed the use of metagenomics to track and perhaps to assign risks that are associated
with ARGs [42–44]. An extensive elaboration of the various studies has demonstrated the use of these
tools, and therefore will not be reiterated in this paper. However, depending on the ARB and ARG
targets, the detection limits provided by qPCR and metagenomics may still not be low enough to allow
protection of human health from these contaminants. Still, various sample concentration techniques
can be applied if this truly is a limitation.
In moving towards selecting targets for environmental monitoring, it is important to recognize
that all tools have limitations. Molecular methods like qPCR cannot directly differentiate between
live or dead hosts, nor whether the DNA was extracellular, bacteria-associated, or phage-associated.
Such distinctions are relevant to fully assessing human and environmental impacts. qPCR is also
limited in that it is necessary to select one gene at a time, though arrays are now available that can
target well over 280 genes [45]. Current high-throughput DNA sequencing platforms generate short
read lengths of up to ~300 bp, which are random in terms of which gene segments are or are not
captured given the “shot-gun” nature of the approach. Various bioinformatics approaches are under
development to identify and classify ARGs that are obtained from shot-gun metagenomics sequencing,
but are limited both by the length and quality of the read as well as the quality of available databases
for identifying the sequences. Currently, several databases and pipelines are available to identify ARGs,
MGEs, and other genes of interest [46–48], but there is need for improved curation and standardization
for comparability purposes. New sequencing platforms, like PacBio, that provide long read lengths
are now available and provide richer information for gene identification and also advance confidence
in assembly. Assembly is the process by which overlapping portions of reads are identified to produce
“contigs” and “scaffolds”, enabling the prediction of genomes and moving towards identifying which
ARB carry which ARGs.
There is no doubt that advances in DNA sequencing technologies will play a significant role
in facilitating future surveillance of ARB and ARGs in the environment. However, sequencing
methods are not inherently quantitative and provide only relative abundance of genes normalized
to total reads. Hence, depending on the sequencing coverage, relative abundance obtained from
sequencing approaches may vary substantially and not be conducive for comparisons across different
studies/sample sets. If combined with a measure of total cell counts or total DNA (e.g., from qPCR of
a universal target, flow cytometry, or direct microscopy), relative abundance of genes can be converted
to total abundance, providing quantitative results. However, this is not yet a common approach and
may not be accurate enough for risk assessments. Improvements are also needed in terms of detection
limits, precision, and accuracy, especially if critical ARB or ARG dose thresholds are found to be very
low or cannot be usefully correlated with genetic markers. Nevertheless, one particular advantage of
metagenomics data is that it can be assembled in order to identify presence of ARBs on an MGE or
within a pathogenic host. Reduction in cost can greatly facilitate the application of DNA-sequencing
based tools to become standard protocols for monitoring ARB and ARGs.
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The next point to consider is which ARB and ARG targets to monitor. Defining which ARB or
ARG are likely to contribute to infection and disease burden has not been straightforward and is often
fraught with uncertainty. Furthermore, ARB are known to be ubiquitously present in nature, even in
“pristine” environments that have not been exposed to antibiotics [49,50]. Yet, bacterial populations
were found to possess ARGs, either intrinsically present in their genome or acquired through HGT of
MGEs. Thus, there is a key need to distinguish ARB and ARGs that are truly representative of risk
relative to the background. Furthermore, as HGT itself is considered as a risk, monitoring a MGE,
such as the clinical integron 1 gene cassette [51], which has been proposed as a comprehensive indicator
of genetic recombination events and antibiotic resistance potential of anthropogenic origin [52], would
be useful. There is, however, some debate about the utility of this marker. This is because most studies
rely on detecting only the integrase gene alone without the detection of the recombinases and promoter
sequence. Hence, the mere detection of integrase gene may not necessarily mean that the downstream
ARGs contained within the gene cassette would undergo HGT (recombination) or be expressed.
Until suitable methods and targets are agreed upon, surveying a wide suite of ARB, ARGs, and
MGEs is advisable, enabling the scientific community to move towards eventually identifying which
targets most meaningfully represent increased disease risks and burdens. It may also be beneficial
to align a portion of environmental surveillance efforts to match the priorities listed in the WHO’s
Combat Plan against Antimicrobial Resistance. Specifically, WHO has listed several pathogens as
priority targets. This list includes carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa,
and Enterobacteriaceae (including Klebsiella, E. coli, Serratia and Proteus) [53].
4. Advancing Risk Assessment Frameworks for ARB and ARGs in Recycled Water
Quantitative microbial risk assessment (QMRA) framework provides a useful starting place
for evaluating the risks that are associated with antibiotic resistance [29,54]. The classical QMRA
typically consists of: (i) problem formulation or hazard identification; (ii) exposure assessment;
(iii) dose-response relationships; and (iv) risk characterization and management (Figure 1). However,
as illustrated here, this framework will require substantial adaptation to understand the risks from
ARB and ARGs [16,55]. In particular, hazards should include both pathogenic and non-pathogenic
ARB and ARGs due to the potential for HGT in the environment and within human hosts; the exposure
assessment should account for HGT of newly acquired ARB in the environment; the dose response
models should account for impacts of ARGs, history of antibiotic use, and HGT within the host. Finally,
risk characterization should include impacts of ARB on infection, treatment delays and/or failures,
and increased risks of both morbidity and mortality.
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• How do treatment processes influence concentrations?
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Figure 1. An overview on how the clas ical quantitative microbial risk as es ment framework can be
applied to understand and as es the risks from antibiotic resistant bacteria and genes.
4.1. Hazards
Deter ining the burdens from antimicrobial resistance exposure requires consideration of the
fol owing contaminants:
4.1.1. Bacteria
Pathogenic ARB are of most direct concern, given that they can lead directly to adverse health
outcomes in terms of increasing duration and failure rates of medical treatment and increasing risk of
death [56]. However, non-pathogenic ARB are also a concern as a reservoir with the potential t transfer
ARG to non-antibiotic resistant pathogens (see D se-Response, and A hbolt et al. [16]). Moreover, ARB
can b more resist t to water treatment than th ir non-resistant counterparts, which prolongs t eir
su vival in the environme t. For example, a recent study revealed that an antibiotic-resistant virulent
E. coli strain persisted longer than the less resistant non-virulent E. coli strain upon solar radiation,
despite both being of the same genus and species [57]. In addition to fecal bacteria, which tend to
be the focus f monitoring, non-fecal-bacteria are also of conc rn. Most opportuni tic athogenic
bacteria are not of fec l origin, but re now the primary source of waterbo n disease in industrialized
countries [58].
4.1.2. Genes
ARGs are subject to mobilization across hosts, via MGEs, which amplifies the risk. They are
considered as “emerging contaminants” that are independent of the ARB host. ARGs are transported
through wastewater treatment processes in multiple states, including as functional genes in bacteria,
on plasmids, encapsulated within phages, and exogenously as extracellular DNA [39,59,60]. HGT
subsequently can occur via conjugation, transduction, and/or transformation. The rate of HGT by
each mechanism has not been extensively quantified in the WWTP, where it would be useful to
identify which mechanisms play the most dominant role. However, inferences can be made from
other ecosystems. To illustrate, transduction rates that are reported for aquatic environments suggest
substantial contribution of bacteriophages to the emergence of bacterial strains with new traits and
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potential antibiotic resistant pathogens. The reported frequencies of HGT vary widely; ranging from
10−2 to 10−10 transductants per recipient cell, the most common values ranging from 10−5 to 10−9,
depending on the environmental matrix, the physiological state of the recipient bacteria and the
bacterium–bacteriophage pair itself [61–63]. The significance of transduction in the environment
has been presented in several recent reviews [38,64,65] and will not be elaborated upon here. When
compared to transduction, similar data on conjugation and transformation in environmental systems
are comparatively limited.
The fate of ARGs after exiting the WWTP still merits consideration, given their potential to remain
functional and to be transformed into and replicate within downstream bacterial hosts. Notable
characteristics of wastewater effluent (namely high nutrient, calcium chloride levels, and presence
of lytic phages, termed as “phage superspreaders”) have been shown to increase cell competency
and transformation frequency [66,67]. However, it is unclear whether or not these factors, along with
other unknown factors, would facilitate exogenous ARGs from wastewater effluent to be taken up
via transformation and at what rate. Although the risks of possible downstream ARG amplification
are greatly reduced after wastewater treatment, where designs typically achieve 3–4 log removal of
bacteria and virus [68,69], the fate and health relevance of exogenous DNA remains largely unknown.
Clearly more information on the fate, transport, and health impacts of ARGs in the scope of water
reuse is needed.
4.2. Exposures
Exposure assessments integrate data with respect to contaminant concentrations, impact of control
processes, and specific exposure volumes for each exposure pathway (e.g., consumption of food
crops, ingestion of water, inhalation) in order to estimate the magnitude and frequency of exposures
(Figure 1). Data for QMRA is most useful if it is quantitative with estimates of associated uncertainty
and variability. For antibiotic resistance exposure assessments, quantitative data on concentrations in
wastewater before and after treatment is needed for ARB, ARGs, and MGEs (see Mitigation Strategies).
Risks are influenced by state of ARGs (i.e., extracellular, bacteria-associated, phage-associated), so
data on the state of ARGs is also important. The methods that were used to collect the relevant data,
including associated challenges and opportunities, are discussed above in Monitoring and Surveillance.
Exposure assessments also require estimates of exposure volumes and intakes. Prior work
established for enteric and opportunistic pathogens is relevant, especially in the context of both potable
and non-potable reuse. For example, exposures are estimated for multiple water reuse scenarios within
the World Health Organization Guidelines for the Safe Use of Wastewater, Excreta and Greywater [31]
and World Health Organization Quantitative Microbial Risk Assessment: Application for Water Safety
Management [29].
4.3. Dose-Response Relationships
Existing dose-response relationships used in QMRA are largely based on human and animal
challenge studies for pathogens without consideration of antibiotic resistance. Antibiotic resistance
may influence bacterial fitness, i.e., relative advantage for survival and proliferation. Therefore,
existing dose-response relationships may not adequately reflect infectivity of antibiotic resistant strains.
Specifically, antibacterial resistance carries a fitness cost that most often reduces growth rate and/or
virulence [70,71]. However, there are some resistance mechanisms with little-to-no impact on growth
rate and/or virulence [70], possibly because they are encoded in plasmids that share long evolutionary
history and hence are highly stable in a particular bacterial host [72]. Occasionally, resistance even
confers a fitness advantage [70,73]. The impact of ARGs on pathogen infectivity is therefore difficult
to predict and is based on the combination of the bacterial species and the resistance mechanisms,
including resistance location (chromosome or plasmid) [70,71]. Dose-response relationships also
do not account for the impact of recent antibiotic use on pathogen infectivity. A recent history
of antibiotic use may allow for resistant strains to proliferate and dominate colonization sites [74].
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New dose-response models are necessary for antibiotic resistant pathogens, especially accounting for
the increased likelihood of infection following antibiotic treatments.
An additional complication with existing dose-response relationships is that risks are modeled
for exposures to single pathogenic strains. Treated wastewater, however, contains complex microbial
communities, inclusive of antibiotic-susceptible, antibiotic-resistant, pathogenic, and non-pathogenic
bacteria. The current dose-response relationships may be insufficient to model risks from exposures
to mixed communities. Exposures to mixed communities may increase the likelihood of pathogens
acquiring ARGs or virulence within the human body through, for example, HGT. Not much is
known about the HGT of ARGs from MGEs or non-pathogenic strains to pathogens inside the
human body. Studies indicate that ingestion of naked DNA containing ARGs is not a direct concern,
as transformation into the commensal mammalian gut microbiota is undetectable [75–78]. This may be
due, in part, to the harsh environment of the mammalian gut and its impact on survival of extracellular
DNA. Furthermore, human-associated phages in gut microflora and fecal wastes do not or rarely carry
ARGs [79]. The potential for gene transfer of ARGs to nose, ear, throat, or skin microbiota has yet to be
studied. Thus, transformation and transduction likely present more risk in the environment, rather
than in the human gut, in terms of potential for propagation via transformation.
Improved dose-response and other experimental data based on a combination of epidemiological
data, animal and human challenge studies, and mathematical modeling are necessary to accurately
characterize risks from exposures to ARB and ARGs during wastewater reuse.
4.4. Risk Characterization and Management
Risk characterization refers to estimating the number of people impacted by the identified hazard,
while management refers to active measures to maintain that level below an acceptable burden. In the
case of antibiotic resistance, the impact of infections will vary depending on whether the outcome
of interest is colonization, infection, treatment failure, illness, or death. Adaptation of the QMRA
framework to antimicrobial resistance will require updating the relationships between infection, illness,
and DALYs necessary to estimate disease burden. For enteric diseases, this conversion is based on a
combination of the: (i) probability of illness given infection; (ii) the probability of various outcomes
given illness (e.g., mild diarrhea, severe diarrhea, or death); and (iii) the severity rating of each outcome
(representative of the impact of disease on one’s well-being). For example, a single rotavirus infection
is equivalent to 0.013 DALYs, based on the assumptions that rotavirus illness lasts seven days, there
is a 97.5% likelihood of mild diarrhea with corresponding severity rating of 0.1, a 2.5% likelihood of
severe diarrhea with a severity rating of 0.23, and a 0.015% likelihood of death [30]. Similar conversion
factors for antimicrobial resistant infections do not yet exist, but are expected to be higher than those
for infections that can be cured by antibiotics. This is because antibiotic-resistant infections are usually
more serious, last longer, and are more likely to lead to death than susceptible infections [56]. Therefore,
adaptation of QMRA for antimicrobial resistant infections will require expanding conversion factors to
account for longer disease duration and greater severity. Expanding conversion factors will require
consideration of country-level differences, as conversion is based on disease surveillance data that
are regionally-bounded, and therefore may not be representative of the population from different
countries [80].
Risk characterization for antimicrobial resistant infections will also require reconsidering the
acceptable disease burden. The WHO acceptable disease burden is defined by DALYs (<10−6 DALYs
pppy). If resistant infections have a higher infection-to-DALY conversion factor than treatable
infections, as expected, risk characterization will have to account for the probability that an infection
is resistant. In contrast, the U.S. EPA defines acceptable disease burden in terms of infections
(specifically < 10−4 infections pppy). Thus, whether or not an infection is resistant will not influence
whether or not the tolerable disease burden is exceeded. Generally, the U.S. EPA and WHO disease
burdens align for enteric diseases (like rotavirus) because the infection-to-DALY conversion factor is at
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or below 0.01 [30]. However, the increased duration and severity of antimicrobial resistant infections
will shift this relationship.
Integrating unique considerations with respect to antibiotic resistance as it relates to the four core
components of the QMRA framework provides a useful conceptual model to understand and mitigate
risks of antibiotic resistance from water reuse. However, substantial modification and better defined
knowledge is required to fully utilize this conceptual model for assessing risks of ARB and ARGs.
5. Mitigation Strategies for Antimicrobial Resistance in Recycled Water
Mitigation and risk assessment ideally go hand in hand, with the latter informing the former with
respect to target endpoints. However, such target endpoints have yet to be defined as risk models
tailored to antimicrobial resistance are still in their infancy. Given the gravity of concern for the spread
of antimicrobial resistance, precautionary action towards adoption and implementation of appropriate
mitigation strategies is warranted. Here, the holistic perspectives of both the “One Health” [81] and
“One Water” [82] paradigms, and their convergence, provide useful guidance. Ideally, mitigation
practices should be in harmony with other environmental and health benefits and tailored to local
conditions and constraints. In terms of endpoints, mitigation and monitoring should complement
each other. Given that antibiotic resistance exists in the background, a reasonable endpoint target
is a level and profile of both ARB, ARGs, and HGT potential that would be comparable to the
background arising from the use of conventional water source. To exemplify, a comparison between
treated-wastewater-irrigated and freshwater-irrigated soils found that ARB and ARG levels were
on the whole identical or sometimes even lower in treated-wastewater irrigated soils [83]. Another
study irrigated soil microcosms with chlorinated or dechlorinated effluents, and did not observe
any significant changes in the ARG levels when compared to microcosms that are irrigated with
deionized water [84]. Still, another study comparing several soils irrigated with treated wastewater
versus a background soil in urban parks of Victoria, Australia found clear elevation of several ARGs
in those soils exposed to treated wastewater [85]. Increased monitoring of multiple endpoints can
provide feedback towards better informing both selection of monitoring targets and optimization of
risk models.
Here, we focus on two general aspects of mitigation: Source prevention and treatment technologies.
5.1. Source Prevention as a Barrier to Downstream Proliferation of ARB and ARGs
Given the existence of antibiotic resistance in the natural background, the concept of source
control is correspondingly focused on human activities that either directly augment this background or
result in conditions that stimulate the elevation and mobilization of antibiotic resistance. An example
of the latter would be dumping of antibiotic-laden waste or heavy metals into waste streams or
aquatic environments and correspondingly imposing pressure on microbial communities both towards
selection of strains carrying ARGs [86]. Thus, continued education towards appropriate antibiotic
use, limited to cases of need in humans and animals remains as a top priority across the board for
combating antibiotic resistance.
In the context of water reuse, it is important to consider the upstream influences on the
WWTP. In particular, several studies have noted that hospital sewage is worthy of special handling
considerations. Hospital sewage is known to contain higher levels of antibiotics, as well as
corresponding ARB and ARGs, and markers of hospital-derived ARGs have been ultimately noted in
water bodies receiving hospital-influenced WWTP effluent [87–89]. Thus, a reasonable consideration
is the requirement of on-site pre-treatment of hospital sewage before discharging to municipal
sewers [90,91]. It is important to also recognize that pharmaceutical manufacturing wastes are
often laden with extremely high levels of antibiotic mixtures and poses a special risk. Especially
for pharmaceutical plants operating in countries with limited or ineffective environmental regulation
and high population, there is special concern [92]. However, in certain instances, it is important
to consider that antibiotics are also taken in domestic households. In a study by Schwartz [93],
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the abundance of ARGs encoding resistance to ampicillin was actually higher in a housing area than
in corresponding clinical wastewater. Thus, even with focused source control, mitigation within the
wastewater and recycled treatment processes makes sense.
Depending on the intended water reuse application, the target endpoints may differ. For example,
potable reuse should be held to a higher standard than non-potable reuse. Given the limited
resources and the need to think holistically regarding the goals of water reuse, more costly treatments
are less justifiable for the latter. Still, exposures associated with non-potable reuse are often
overlooked. For example, aerosols can carry opportunistic pathogens, such as Legionella pneumophila
and Pseudomonas aeruginosa, which can cause pneumonia or colonize the skin and cause infections later
when the dermal layer is compromised [94]. Thus, it is important in identifying mitigation strategies
to also manage the safety of the water if it is piped to a different location for reuse. In particular,
there is also a need to consider preventing regrowth in the distribution system. Currently, there is
little to no guidance specifically for managing water reuse distribution systems, with consideration
needed for whether the water is used to irrigate crops, irrigate recreational fields, or other activities.
Basic questions such as the ideal disinfectants, water storage conditions and water age management
need to be also addressed.
Regardless of the intended reuse purpose or local constraints, the need and benefits of basic
sanitation and hygiene are crystal clear. This is well-illustrated by work documenting the elevation of
the multi-antibiotic resistance-associated genetic element encoding New Delhi metallo beta-lactamase
NDM-1, in surface waters during pilgrimage to remote sites in India without sanitation facilities [95]
and in the recovery of NDM-positive E. coli pathogen in untreated wastewater in Saudi Arabia during
the Hajj pilgrimage month [96]. Thus, an important message is that WWTPs are not to blame. Instead,
they are a key aspect of the solution.
5.2. Treatment Technologies to Remove ARB and ARGs
WWTPs typically employ several steps, including physical, biological and chemical processes.
A recent surge in research is beginning to provide insight into the relative effects of these treatments
on ARBs and ARGs. In terms of general bacterial removal, it is estimated that the concentration of
bacteria in wastewater influent and final effluent are about 109–1012 colony forming unit (CFU)/day
and 104–106 CFU per day per inhabitant equivalent, respectively [97]. Within a typical WWTP, ARB,
and ARGs specifically may be removed via several processes, but there is also potential to increase if
the conditions preferentially select for ARB [68,98] or promote the potential for HGT [99].
Initial screening and settling of primary sewage influent produces primary sludge, which may be
subject to further treatment via sludge digestion and the residuals reused as a soil amendment. While
the physical processes that are applied to primary sludge will reduce the load of bacteria, including
ARB, to subsequent stages of treatment, it is important to also consider the effects to agroecosystems
when residuals are land applied. The effects of residuals application to soil and crops varied depending
on the region and do not always elevate ARB and ARGs, but the potential of residual antibiotics and
metals to select and influence horizontal transfer of ARGs in soils [94–96] and subsequently to crops is
a legitimate concern. Because of such concerns and other unknowns, land application has been avoided
in some countries. Instead, the incineration of antibiotic-laden sludge generated by conventional
WWTPs have been opted by some countries to be a better solution in reducing antibiotics, ARB, and
ARGs than land application [100].
Following primary treatment, biological treatment is usually employed as an economical means
of removing organic matter, nutrients, and other pollutants in the water. Specific biological treatment
processes are highly variable, from suspended floc growth in the case of standard activated sludge
treatment to attached biofilm processes, and mixed aerobic and anaerobic stages for biological nutrient
removal. Following primary treatment, the water still contains some raw-sewage associated bacteria
and several field studies have been conducted tracking ARB and ARGs through various biological
treatment processes [68,101,102]. General log removal value (LRV) of bacteria following biological
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treatment is typically around 1-log, while the specific effects on ARB and ARGs are relatively more
varied, which may be reflective of the nature of the sewage, process performance, climatic and
unknown factors.
A general concern is that because biological treatment by nature depends upon highly
concentrated and active bacteria that are interacting with influent pathogens and ARGs, along with
residual metals and antibiotics, WWTPs could be a “hot spot” for the transfer of ARGs [60,103–107].
One recent study showed a positive correlation between the solids retention time and numbers of
Gram-positive ARB [108], demonstrating that nutritional status of the bacteria and the time of exposure
to antibiotics and other selective agents in the aeration basin can play a role in promoting antibiotic
resistance. On the other hand, attempts to estimate HGT rates in activated sludge suggest that it is
not an overly common phenomenon in WWTPs relative to background [109], although more work
is needed to confirm this observation. In any case, while biological treatment surely will and should
remain as an important pillar to wastewater treatment, it is doubtful that it can be relied upon fully for
the reduction of ARB and ARGs. Therefore, other downstream barriers should be explored, especially
when intending the water for reuse.
Tertiary treatments of WWTP effluents for the purpose of non-potable reuse are usually comprised
of filtration (typically granular media filtration or membrane filtration, such as micro- or ultra-filtration),
and disinfection. Chlorination is one of the most used disinfection systems to decrease the total
amount of bacteria in wastewater effluents. However, questions remain with respect to the ability of
impaired bacteria to survive and regrow, especially in water reuse distribution systems [94]. According
to the WaterVal chlorine disinfection validation protocol [110], based on the U.S. EPA disinfection
profiling and benchmarking guidance manual [111], a treatment plant could validate for a 2-log
LRV of bacteria by using a typical CT (i.e., concentration of disinfectant multiplied by contact time)
value of 5 mg·min/L at 20 ◦C, pH 7–7.5 and turbidity ≤5 NTU. However, several studies showed
an increase of the proportion of ARB over a typical dose range (0.5–5 mg/L) and CT value used
in WWTPs [112–115]. In contrast, higher dose and CT values (i.e., lethal doses) result in extensive
fragmentation and precipitation of DNA-protein complexes [116], which may signify a good way
to reduce ARB and ARGs. At extremely high doses (e.g., 80 mg Cl·min/L), Guo and coworkers
demonstrated that ARG transfer was greatly suppressed [112], but such a high dose is not practical and
could have other consequences. Besides the formation of toxic, carcinogenic disinfection byproducts
(DBPs), which would significantly increase the chemical risks that are associated with water reuse,
work has also shown that the DBPs produced by chlorination could also select for ARGs [99]. Thus, the
ultimate impact of chlorine on ARB and ARGs is still debatable and it is not wise to rely on chlorination
as the sole barrier.
Ultraviolet (UV) disinfection is an alternative to chlorine since it does not produce toxic DBPs,
prompting many WWTPs to switch from chlorine to UV. According to the U.S. EPA ultraviolet
disinfection guidance manual [117], the required dose to achieve 2-log inactivation for Cryptosporidium,
Giardia and virus is 5.8, 5.2 and 100 mJ/cm2, respectively. In addition, the guidelines recommend
that the highest UV dose would be 186 mJ/cm2 to achieve 4-log inactivation of viruses. This is
generally thought to be sufficient to kill most co-occurring bacteria, since viruses are generally harder
to inactivate than bacteria. However, an earlier study has found that, while this recommended dose
would be sufficient to inactivate ARB (10 to 20 mJ/cm2 to achieve 5-log inactivation), it would result
in varying efficacies in removing different types of ARGs. For instance, tetA and ampC genes (which
confer resistance against tetracycline and ampicillin, respectively) would only be reduced by 1 to
2-log, while mecA and vanA (which confer resistance against methicillin and vancomycin, respectively)
would be reduced by 3 to 4-log [34]. This large variation in inactivation efficiencies suggests a selective
enrichment of certain types of ARGs that may be more resistant against UV treatment in the final
treated water. Prior work demonstrated that the nature of the DNA sequence (e.g., number of adjacent
thymine bases) dictates the susceptibility of ARGs to UV disinfection [34]. Collectively, these findings
seem to suggest that tertiary treatment processes demonstrate limited effectiveness at removing ARB
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and ARGs. However, it remains unknown if the corresponding risks levels arising from the remnant
ARB and ARGs would exceed that of the acceptable level for non-potable reuse.
Beyond tertiary treatment, advanced treatment, including ozone, advanced oxidation processes
(AOPs, which generally involve in-situ production of reactive hydroxyl radicals in the presence
of primary oxidant and/or energy source or catalysts), and nanofiltration or reverse osmosis can
be used as an additional treatment for non-potable or potable reuse. Ozone (O3) is a disinfectant
that is becoming increasingly popular in water reuse treatment trains. Ozone is a strong oxidizing
agent that can fragment contaminants and other organics, thus making these contaminants more
amenable to biodegradation. In the case of antibiotic resistance, ozonation and other advanced
oxidation processes are promising because they can move past pathogen destruction and actually
destroy DNA and potentially block the ability of downstream bacteria to acquire antibiotic resistance
via transformation [55]. However, as is the case for the other disinfection processes that are cited
here, studies focused on effects of ozone are not fully conclusive and ultimate use of ozonation would
be very costly. Lüddeke et al. [118] studied the removal of total bacteria and ARB in pilot-scale
advanced wastewater treatment by ozone in combination with different filtering techniques (i.e., sand
filtration and/or granulated activated carbon). Ozone was able to improve bacterial removal by about
1 LRV with a contact time of 20 min in the presence of 0.73 mg O3/mg dissolved organic carbon.
However, the study shows that the total level of resistant E. coli and Staphylococcus spp. isolates
increased. According to Sigmon et al. [119], ozone is able to remove around 2 LRV of E. coli with a CT
of 0.65 mg·min/L at pH 7.6, a temperature of 16 ◦C and a total organic carbon (TOC) concentration
of 17.1 mg/L. This reported disinfection strategy achieved approximately the same CT value as that
in the study of Luddeke et al. [118]. However, pH and temperature of the experiment in that study
was not measured. These findings demonstrate that environmental or operating conditions can have a
significant influence on the final LRV achieved.
On the other hand, combining chlorine (i.e., an oxidant) with UV (i.e., energy source) was shown
to achieve higher log reduction for ARGs like sul1, tetX, tetG, and MGEs intI1 than using either
disinfection strategy alone [120]. The maximum reported LRV for tetX was approximately 2.2-log
with 249.5 mJ/cm2 of UV irradiation in combination with 30 mg/L chlorine. This is in contrast to
approximately 0.6 LRV from the same UV fluence alone and 1.5 LRV from the same concentration of
chlorine [120]. It is important to note that the amount of UV irradiation and chlorine to be added to the
wastewater effluent to achieve this reported LRV is exceedingly high and may be costly for long-term
operations. Another study demonstrated that the combination of UV and H2O2 was able to reduce
the UV fluence from ca. 65 mJ/cm2 to 40 mJ/cm2 for the same LRV of 3 when extracellular ampicillin
resistance genes were suspended in phosphate saline buffer. However, when the same extracellular
ampicillin resistance genes were suspended in wastewater effluent, the combination of H2O2 and
UV result in neither a significant reduction in the UV fluence that is required to achieve the same log
reduction, nor improvement in overall log reduction of ARGs [121]. These findings demonstrate that
while AOP can potentially be useful for inactivating ARGs in wastewater matrices, the additional costs
associated with using an oxidant in tandem with an energy source may not be entirely justified.
Among all of the available treatments that are commonly applied for water reuse, membrane
treatments are most likely to be effective. Membrane treatment options ranked from the loosest to
tightest size removal criteria include: microfiltration (MF), ultrafiltration (UF), nanofiltration (NF) and
reverse osmosis (RO). MF, UF, and NF would suffice if the treated water is intended for non-potable
reuse purpose while an additional RO step is typically used to achieve a final product suitable for
potable reuse. MF, UF, and NF membranes are commonly applied in tandem with activated sludge
treatment as an alternative to a settling tank. LRV of bacterial contaminants reported by MBRs are
collated in a recent review paper [41]. When comparing the reported influent and effluent abundances
of bacteria, it is apparent that membranes are a well-established barrier to remove bacteria at high
LRV, but whether these reported LRVs can be translated to ARB would remain unknown. This is
because antimicrobial molecules are known for inducing alterations in the bacterial envelope and in its
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mechanical properties [122,123]. Variances in cell rigidity may apply to ARB, which can consequently
trigger passage of ARB through membranes at a different rate than non-antibiotic bacterial cells.
Besides size exclusion, other factors, such as adsorption onto the membrane, can also aid in removing
ARB and ARGs from wastewater. In fact, adsorption may play a more important role in removing
ARGs than size exclusion alone. This is because studies have indicated that naked DNA containing
ARGs could be effectively removed by fouled UF [124] and MF membranes [125]. These are promising
results since UF- and MF-based MBRs are typically operated at lower energy requirement than NF or
RO, and thus incur lower costs.
Membrane separation processes can also be applied together with anaerobic fermentation process
to further lower energy and costs that are required to operate MBRs. Life cycle analysis revealed
that anaerobic membrane bioreactors (anMBRs) hold promise in providing a sustainable way to treat
municipal wastewater due to its capacity to produce methane that can be harvested to become an
energy source and its low solid waste production rate [126]. This is in contrast to the aerobic MBRs,
which require energy for aeration and generate large volumes of antibiotics-laden sludge requiring
disposal. Recent studies also suggest that anMBR may provide treated effluent that is safer than that
produced by aerobic MBR. This is exemplified from the higher removal rates of the majority of the
detected bacterial contaminants than aerobic MBR [127], and a lower occurrence of ARGs in anMBR
than aerobic MBR when exposed to similar concentrations of antibiotics [128]. However, anaerobic
processes alone do not remove ammonia and phosphorus from municipal wastewaters, and can result
in environmental concerns (e.g. eutrophication in surface waters) or breaches in the potable water
quality when used upstream of a water reclamation plant. Hence, combining aerobic and anaerobic
processes by using sequential redox conditions to select/remove different types of ARB and ARGs
with lower energy use and nutrient removal may be the ultimate solution [129].
Overall, it is reasonable to conclude that the advanced treatment processes applied in potable
reuse treatment trains are likely to reduce ARB and ARGs to levels that are negligible compared to
background concentrations [130].
6. Concluding Statement
There is an urgent need to more comprehensively evaluate resulting environmental and public
health concerns that may arise from water reuse. A growing volume of research has brought to light
the ubiquitous presence of ARB and ARGs in wastewater and has demonstrated that conventional
WWTPs do not fully remove these contaminants from the final treated effluent. Despite mounting
scientific evidence, existing regulations and policies have yet to determine permissible levels of ARB
and ARGs in final treated water. A “One Water” framework in which multiple barriers are emplaced
to protect public health is advisable. Addressing various knowledge gaps that were highlighted in
this perspectives paper, including the need to identify suitable targets and inadequate risk assessment
models, can help to facilitate effective recycled water management to ensure utmost protection of
public health. In the meantime, it is important to consider both source prevention and treatment
technologies to minimize the potential detrimental impact arising from ARB and ARGs in wastewaters.
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